Business · 27/03/2008

FDA Releases Draft Guidance for Coronary Drug Eluting Stents Nonclinical and Clinical Studies

The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry on conducting nonclinical and clinical studies for coronary drug eluting stents (DES) to support a marketing application. The guidance provides recommendations for clinical studies and data submission to support such an application.